Suchergebnisse - "Huijberts, Sanne"

PubPharm (14)

1

Phase I Study of Afatinib and Selumetinib in Patients with KRAS-Mutated Colorectal, Non-Small Cell Lung, and Pancreatic Cancer

enthalten in: The oncologist | 2021

von van Brummelen, E. | Huijberts, S. | van Herpen, C. | +12

2

Mutational profiles associated with resistance in patients with BRAFV600E mutant colorectal cancer treated with cetuximab and encorafenib +/- binimetinib or alpelisib

enthalten in: British journal of cancer | 2021

von Huijberts, S. | Boelens, M. | Bernards, R. | +1

3

Phase I Study of Afatinib and Selumetinib in Patients with KRAS‐Mutated Colorectal, Non‐Small Cell Lung, and Pancreatic Cancer

enthalten in: The oncologist | 2021

von Brummelen, E. | Huijberts, S. | Herpen, C. | +12

4

Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancer

enthalten in: Cancer chemotherapy and pharmacology | 2020

von Huijberts, S. | van Geel, R. | van Brummelen, E. | +11

5

Vorinostat in patients with resistant BRAFV600E mutated advanced melanoma : a proof of concept study

enthalten in: Future oncology (London, England) | 2020

von Huijberts, S. | Wang, L. | de Oliveira, R. | +6

6

Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancer

enthalten in: British journal of cancer | 2020

von van Geel, R. | van Brummelen, E. | Eskens, F. | +14

7

Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancer

enthalten in: Cancer chemotherapy and pharmacology | 2020

von Huijberts, S. | van Geel, R. | van Brummelen, E. | +11

8

Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancer

enthalten in: Cancer chemotherapy and pharmacology | 2020

von Huijberts, S. | van Geel, R. | van Brummelen, E. | +11

9

Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancer

enthalten in: Cancer chemotherapy and pharmacology | 2020

von Huijberts, S. | van Geel, R. | van Brummelen, E. | +11

10

Encorafenib, binimetinib and cetuximab combined therapy for patients with BRAFV600E mutant metastatic colorectal cancer

enthalten in: Future oncology (London, England) | 2020

von Huijberts, S. | van Geel, R. | Bernards, R. | +2